Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

We also know that nearly 20% of patients with GA develop wet AMD within 3 years, which is another reason to have a retina specialist involved sooner rather than later. For GA, retina specialists ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in melanoma, dashing its hopes of moving the drug earlier in the treatment pathway.

Dr. Aditya Bansal University of Kentucky When you think of cancer, eye cancer may not be the first thing that comes to mind.